The proprietary products division of a generic drug maker got favorable results from a clinical...
Drug maker Eli Lilly & Co. unveiled a plan Monday that it hopes will speed...
A drug that recently received an expanded approval from the Food and Drug Administration as...
A new report by Decision Resources found that an angiogenesis inhibitor will garner sales of...
Amylin Pharmaceuticals has partnered with an Indian drug maker to develop a diabetes drug using...
Drug maker Endo Pharmaceuticals announced the introduction of a drug that it says fills an...
A company that manufactures blood glucose monitors plans to buy the company that distributes them....
An Australian drug maker has submitted its approval application to the Food and Drug Administration...
A privately held specialty pharmaceutical company announced that the founder and former chairman of Dendrite...
A Food and Drug Administration advisory committee has given a favorable review to a new...
While H1N1 swine flu has hogged most of the publicity in the last few months,...
A Norwegian company that develops cancer drugs has signed a deal potentially worth nearly $1...
Patients using a health insurer’s specialty pharmacy have shown higher medication adherence, according to a...
Patients taking a drug for organ transplants have reported experiencing a type of anemia, the...
A global biopharmaceutical company has completed its tender offer of all outstanding common stock of...
A Food and Drug Advisory Committee considered whether to approve a drug for treating acute...
A decline in demand in North American markets has prompted a drug maker to close...
Patients with acute coronary syndrome didn’t fare better when receiving increased doses of a popular...
The Food and Drug Administration has notified healthcare professionals and patients of a change to...
Patients receiving an investigational biotech drug for lupus got better results than those taking placebo,...
Drug makers Pfizer and Abbott Labs have announced they will develop a test and therapy...
Biotech company Amgen got lackluster results from a late-stage clinical trial of a drug in...
Healthcare costs are expected to increase on average 10.5% in the next 12 months, Aon...
A U.S. drug maker has signed an agreement with a company in the United Kingdom...
An investigational drug was effective in treating patients with schizophrenia, according to late-stage clinical trial...